Intermediate filament cytoskeleton of the liver in health and disease by Strnad, P. et al.
Histochem Cell Biol (2008) 129:735–749
DOI 10.1007/s00418-008-0431-x
123
REVIEW
Intermediate Wlament cytoskeleton of the liver in health 
and disease
P. Strnad · C. Stumptner · K. Zatloukal · H. Denk 
Accepted: 14 April 2008 / Published online: 29 April 2008
© Springer-Verlag 2008
Abstract Intermediate Wlaments (IFs) represent the largest
cytoskeletal gene family comprising »70 genes expressed
in tissue speciWc manner. In addition to scaVolding func-
tion, they form complex signaling platforms and interact
with various kinases, adaptor, and apoptotic proteins. IFs
are established cytoprotectants and IF variants are associ-
ated with >30 human diseases. Furthermore, IF-containing
inclusion bodies are characteristic features of several
neurodegenerative, muscular, and other disorders. Acidic
(type I) and basic keratins (type II) build obligatory type I
and type II heteropolymers and are expressed in epithelial
cells. Adult hepatocytes contain K8 and K18 as their only
cytoplasmic IF pair, whereas cholangiocytes express K7
and K19 in addition. K8/K18-deWcient animals exhibit a
marked susceptibility to various toxic agents and Fas-
induced apoptosis. In humans, K8/K18 variants predispose
to development of end-stage liver disease and acute liver
failure (ALF). K8/K18 variants also associate with devel-
opment of liver Wbrosis in patients with chronic hepatitis C.
Mallory-Denk bodies (MDBs) are protein aggregates con-
sisting of ubiquitinated K8/K18, chaperones and sequesto-
some1/p62 (p62) as their major constituents. MDBs are
found in various liver diseases including alcoholic and non-
alcoholic steatohepatitis and can be formed in mice by
feeding hepatotoxic substances griseofulvin and 3,5-dieth-
oxycarbonyl-1,4-dihydrocollidine (DDC). MDBs also arise
in cell culture after transfection with K8/K18, ubiquitin,
and p62. Major factors that determine MDB formation in
vivo are the type of stress (with oxidative stress as a major
player), the extent of stress-induced protein misfolding and
resulting chaperone, proteasome and autophagy overload,
keratin 8 excess, transglutaminase activation with transami-
dation of keratin 8 and p62 upregulation.
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Intermediate Wlaments in health and disease
Together with the actin microWlaments and the micro-
tubules, intermediate Wlaments (IFs) are the components of
the cytoskeleton of eukaryotic cells, which is involved in
the maintenance of cell shape, locomotion, intracellular
organization, and transport (Bershadsky and Vasiliev 1988;
Ku et al. 1999). IF proteins comprise a large family, which
includes »70 diVerent genes (Omary et al. 2004; Kim and
Coulombe  2007; Herrmann et al. 2007; Goldman et al.
2008). They are further divided into six subtypes (Table 1),
which are, at least in part, expressed in a cell type (and
diVerentiation)-dependent manner (Omary et al. 2004; Kim
and Coulombe 2007; Goldman et al. 2008). Accordingly,
IFs serve as cell type markers and antibodies to IF proteins
are widely used today in diagnostic pathology (Wick 2000;
Barak et al. 2004). Individual IF proteins consist of a con-
served central coiled-coil -helical rod domain (interrupted
by linkers) which is Xanked by N-terminal (head) and
C-terminal (tail) domains (Omary et al. 2006; Godsel et al.
2008; Kim and Coulombe 2007; Herrmann et al. 2007;
Goldman et al. 2008). The N- and C-terminal domains
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contribute to the structural heterogeneity and are major
sites of posttranslational modiWcations with phosphoryla-
tion being the best characterized one (Omary et al. 1998;
2006). This makes them important regulatory domains,
since dynamic changes in phosphorylation status are
responsible for alterations in IF dynamics, solubility, and
organization (Omary et al. 2006).
In addition to the posttranslational modiWcation, IF func-
tion is modiWed and complemented through interaction
with a variety of IF-associated proteins (IFAP; Table 2;
Green et al. 2005; Omary et al. 2006; Kim and Coulombe
2007). These proteins can be subdivided into several sub-
groups, which reXect multiple IF functions (Green et al.
2005). For example, IFs interact with a variety of anchoring
proteins thereby forming transcellular networks which
contribute to proper tissue architecture. IFAPs also include
several cytolinker proteins, which provide the structural
framework for coordinated cytoskeletal function (Table 2).
By doing that, they are important mechanical stabilizers
and accordingly, IF disruption results in increased mechani-
cal fragility (Omary et al. 2004; Ku et al. 2007; Herrmann
et al. 2007). The scaVolding function of IFs is best seen in
IF-deWcient animals, who exhibit disrupted cellular archi-
tecture, protein mistargeting as well as alterations in orga-
nelle localization and function (Toivola et al. 2005). In the
case of lamin deWciencies, the impairment of nuclear com-
position has profound impact on many aspects of normal
nuclear functions such as epigenetic changes, chromatin
organization or DNA transcription, and repair (Dechat et al.
2008).
IFs are not just simple cellular scaVolds, they rather
build complex signaling platforms (Pallari and Eriksson
2006; Kim and Coulombe 2007). IFs interact with a variety
of enzymatic and adaptor proteins, thereby aVecting a multi-
tude of cellular functions. For example, keratins associate
with 14-3-3 proteins in a phosphorylation-dependent man-
ner and this interaction regulates cell growth and cell cycle
progression (Ku et al. 2007; Kim and Coulombe 2007). IF
Table 1 Intermediate Wlament proteins
a  Not a causative association, variants represent a risk factor. For an overview about the new keratin nomenclature, see Schweizer et al. (2006)
Type Name/Localization Disease location Remarks
I (n = 28) K9-28 (epithelia) K10,14,16,17-skin Acidic keratins
K31-40 (hair/nail) K12-cornea (pI < 5.7)
K13-stratiWed mucosa Type I/II obligate 1:1 polymers
K16,17-nail
K18a-liver
II (n = 26) K1-8, K71-80 (epithelia) K1,2e,5,9-skin Basic keratins
K81-86 (hair/nail) K3-cornea (pI ¸ 6.0)
K4-stratiWed mucosa Type I/II obligate 1:1
K6a,6b-nail polymers
K8a-liver
K75a,81,83,85,86-hair
III Desmin (muscle) Muscle, heart Desmin, vimentin and GFAP are 
found in stellate cells Vimentin (mesenchymal)
Peripherin (neurons) Braina, spinal corda
GFAP (astrocytes/glia) Brain
IV NF-L (neurons) Braina, spinal cord -internexin forms polymers with NFs
NF-M (neurons) Braina, spinal corda
NF-H (neurons) Brain, spinal corda Synemin  is also called desmuslin.
-internexin (CNS neurons) Nestin-stem cell marker
Synemins (muscle)
Syncoilin (muscle)
Nestin
V Lamin A/C (ubiquitous) Heart, muscle, fat, premature 
aging, complex defects
The only nuclear IFs, longer rod domain
Lamin B1/2 (ubiquitous)
Orphan Phakinin (lens) Lens Beaded Wlaments in lens epithelia
Filensin (lens) LensHistochem Cell Biol (2008) 129:735–749 737
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phosphorylation through associated kinases does not only
regulate IF properties, but IFs also serve as phosphate
“sponge” thereby preventing activation of other, potentially
pro-apoptotic, substrates (Omary et al. 2006; Ku et al.
2007). In addition to that, IFs also directly participate in
apoptosis regulation through binding of several apoptosis-
related molecules (Marceau et al. 2007).
In contrast to the actin and tubulin system, IFs emerged
later in the evolution and are important supportive elements
of the cell rather than their essential components. There-
fore, IF variants are observed in various human diseases,
which reXect their tissue speciWc distribution, whereas only
few actin and tubulin variants have been described so far,
likely due to their embryolethality (Ku et al. 1999; Omary
et al. 2004). Currently, more than 30 diseases are caused
by/associated with IF mutations (Omary et al. 2004).
Among them, keratin-related- and lamin-related disorders
are the best studied ones. For example, mutations in kera-
tins 5/14 cause a blistering skin disease termed Epider-
molysis bullosa simplex, whereas mutations in lamins A
and C result, among others, in diVerent diseases including
premature aging, cardiomyopathy, and lipodystrophy
(Omary et al. 2004; Dechat et al. 2008).
The disease relevance of IFs is also highlighted by a vari-
ety of IF-containing inclusion bodies, which represent the
pathological hallmarks of several neurodegenerative, muscu-
lar, and other disorders (Goebel 1998; Ross and Poirier 2004;
Omary et al. 2004; Cairns et al. 2004). These aggregates
share a variety of features such as presence of misfolded,
ubiquitinated structural proteins together with variable
amounts of chaperones and p62 (Kuusisto et al. 2001; Zat-
loukal et al. 2002; Ross and Poirier 2004). Among the IF-
related inclusions, Mallory-Denk bodies (MDBs) are the
most common and also the best studied ones due to the avail-
ability of animal MDB models (Denk et al. 1975; Yokoo
et al. 1982; Jensen and Gluud 1994; Denk et al. 2000; Zat-
loukal et al. 2007). Therefore, one focus of our review will be
to describe MDB as a prototype of IF-related inclusion body,
which should oVer useful insights into the formation of IF-
related aggregates in multiple human diseases.
Keratins as epithelially expressed IFs
Keratins represent the largest subfamily of IFs consisting
of >50 unique gene product members (Schweizer et al.
2006; Kim and Coulombe 2007; Godsel et al. 2008) which
include 37 epithelial and 17 hair keratin members in
humans (Table 1; Schweizer et al. 2006). Based on their
pI, epithelial keratins can be subdivided in types I (acidic)
and II (basic) corresponding to keratins 9–20 (K9¡K28)
and keratins 1–8 plus keratins 71–80 (K1–K8; K71–K80),
respectively (Table 1; Coulombe and Omary 2002; Schwe-
izer et al. 2006). Keratins are found as obligatory type I
and type II heteropolymers (i.e., consisting of at least one
type I and one type II keratin) and a homozygous disrup-
tion of a keratin results in degradation of its keratin partner
at the protein level (Ku and Omary 2000; Omary et al.
2004). Similarly to IFs, keratins are expressed in a tissue-
speciWc manner, with diVerent pairs being the major cellu-
lar IFs in diVerent cell populations (Moll et al. 1982; Ku
et al.  1999; Coulombe and Omary 2002). For example,
“simple” (i.e., single layered) epithelia, as found in diges-
tive organs, express K8 together with variable levels of
K7, K18, K19, and K20 depending on the tissue (Moll
et al. 1982; Ku et al. 1999; Coulombe and Omary 2002;
Ku et al. 2007). In contrast, stratiWed epithelia, like epider-
mis, express K5/K14 in the basal and K1/K10 in the supra-
basal keratinocytes, respectively (Moll et al. 1982; Lane
and McLean 2004; Coulombe and Omary 2002). Despite
their similar molecular composition, “simple” and “strati-
Wed” keratins are not interchangeable, as shown in K14-
null mice, whose phenotype was only partially restored by
addition of K18 (Hutton et al. 1998). Furthermore, kera-
tins have their preferential binding partners in vivo and the
lack of such partner leads to their rapid degradation
(Magin 1998). This contrasts with the in vitro situation,
where IF assembly is more promiscuous (Hatzfeld and
Franke 1985).
K8/K18/K19 are promising serological markers based
on their high abundance (approximately 0.3% of total liver
protein) and intracellular localization under basal condi-
Table 2 Examples of IF-asso-
ciated proteins
Type of interaction Examples Function
Anchoring Desmoplakin, BPAG1, -dystobrevin Tissue architecture
Cytolinker Plectin, Filaggrin, Cellular architecture
Chaperones Hsp27, -B-crystallin, Hsp70 Protein folding
Kinases PKC, Cdk5 IF regulation, phosphate sink, 
cell cycle
Adaptor proteins 14-3-3 protein, AP-3 Multiple eVects
Membrane proteins Polycystin-1 Unknown
Apoptotic proteins TRADD, TNFR2, C-Flip, Caspase3/9 Apoptosis regulation
Motor proteins Dynein, Kinesin Movement of IF components738 Histochem Cell Biol (2008) 129:735–749
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tions with release into blood upon liver injury (Omary et al.
2002; Ku et al. 2007). However, one important caveat is the
fact, that K8/K18/K19 are expressed in most simple epithe-
lial cells and are therefore not liver-speciWc (Moll et al.
1982; Ku et al. 1999).
The K8/K18/K19 epitopes used in serologic diagnosis
can be divided into two classes, that is, non-speciWc and
apoptosis-generated epitopes. The former class constitutes
established tumor markers such as tissue polypeptide anti-
gen (TPA, represents total K8/K18/K19), tissue polypep-
tide speciWc antigen (TPS, derived from K18), and
CYtokeratin FRAgment 21-1 (CYFRA 21-1, derived from
K19). Their original clinical use was to monitor treatment
response and to detect recurring tumors (Barak et al. 2004).
However, later studies showed that these epitope serum lev-
els are also elevated in non-malignant diseases and might
be a general marker of tissue injury (Gonzalez-Quintela
et al. 2006a, b; Tarantino et al. 2007).
The apoptosis-speciWc keratin antibodies are based on
the Wnding, that type I keratins are cleaved at a conserved
VEMD/VEVD residue during apoptosis. In addition to
that, K18 posseses a second, K18 speciWc caspase-cleav-
age site at Asp396, which is an early event during apopto-
sis preceding the cleavage at the VEMD/VEVD motif
(Oshima  2002; Marceau et al. 2007). The cleavage of
human K18 at Asp396 can be monitored using the M30
antibody (Leers et al. 1999) and M30-Ab ELISA has
become a useful serologic test for determining liver dis-
ease severity. For example, elevated serum M30 titers can
distinguish simple steatosis from non-alcoholic steatohep-
atitis (Wieckowska et al. 2006) and predict several impor-
tant prognostic parameters in patients with chronic
hepatitis C infection (Bantel et al. 2004; Volkmann et al.
2006).
As another tool for detecting apoptotic keratin frag-
ments, an antibody speciWc to the conserved K18/K19
cleavage site at Asp237 was recently generated (Tao et al.
2008). It detects both mouse and human K18/K19 frag-
ments and appears to be more sensitive than the established
Asp396-Ab (Tao et al. 2008). Measuring the serum levels
of apoptosis-speciWc keratin fragments should also improve
our understanding of chronic liver disease, where apoptotic
cell death is an important pathogenic feature (Malhi et al.
2006).
In addition to that, monitoring the phosphorylation status
of the circulating keratin fragments might be useful. Kera-
tins undergo dynamic phosphorylation during mitosis,
apoptosis and a variety of stress situations (Omary et al.
1998; Omary et al. 2006) and their in situ phosphorylation
status is a marker of human liver disease progression (Toi-
vola et al. 2004). However, it is currently unknown whether
the phosphorylation status of the circulating keratin frag-
ments correlates with the situation in situ.
Hepatic phenotype in keratin-deWcient transgenic 
animals
The liver consists of diVerent cell types with characteristic
IF composition (Table 3; Omary et al. 2002). Adult hepato-
cytes are unique among simple epithelial cells in that they
express exclusively K8 and K18, whereas other glandular
epithelia exhibit a more complex keratin expression pattern
(Omary et al. 2002; Ku et al. 2007). The hepatocytic keratin
IF network is dense, particularly around bile canaliculi and
at the cell periphery, and acts as cytoskeletal backbone to
the functionally more dynamic and contractile actin micro-
Wlament system (Zatloukal et al. 2004). Biliary epithelial
cells diVer from hepatocytes by additional expression of
keratin 7 and 19 (Omary et al. 2002; Zatloukal et al. 2004).
Keratins in cholangiocytes, but not hepatocytes, exhibit
polarized and compartment-speciWc expression pattern
(Omary et al. 2002; Zatloukal et al. 2004). The biological
signiWcance of such an expression is enigmatic, but it may
be related to polarity and secretory processes. Among non-
epithelial cells, stellate cells express variable amounts of
GFAP, desmin, vimentin, and nestin dependent on their
activation status, localization, and other parameters
(Table 3; Geerts 2001).
Studies in keratin knock-out mice revealed that the regu-
lar liver development does not require the presence of K8,
K18, or K19 (Ku et al. 2007). However, K8/K18 knockout
mice exhibited mild chronic hepatitis, hepatocyte fragility
and were markedly more sensitive to a variety of stress con-
ditions (Omary et al. 2002; Zatloukal et al. 2004; Ku et al.
2007). Furthermore, K8/K18 transgenic mice were developed,
which over-express diVerent single-amino-acid variants
(Ku et al. 2007). Among them, the K18 R89C variant
resulted in disruption of hepatocyte IF network and exhibited
a phenotype reminiscent of the situation in K8/K18-
knockout mice (Ku et al. 1995, 1996). K18 R89C mice also
Table 3 IFs of liver cell populations
ModiWed from Omary et al. (2002)
a  During embryogenesis, hepatocytes also express variable levels of
K19 (Vassy et al. 1997)
b  Stellate cells represent a highly heterogeneous population with var-
iable IF expression dependent on species, activation status of the cell,
location within the hepatic lobe and many other parameters (Geerts
2001)
Cell type IF composition
Hepatocyte K8/K18a
Oval cells K7/K8/K18/K19
Cholangiocyte K7/K8/K18/K19
KupVer cell Vimentin
Stellate cell GFAP, Vimentin, Desmin, Nestinb
Endothelial cell VimentinHistochem Cell Biol (2008) 129:735–749 739
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predisposed to development of thioacetamide-induced liver
Wbrosis (Strnad et al. 2008). Ablations of diVerent K8/K18
phosphorylation sites usually led to a somewhat milder
phenotype which became apparent in stress situations, but
not under basal conditions (Ku et al. 2007). For example,
K18 S52A variant resulted in increased sensitivity to micro-
cystin-LR-induced liver injury, whereas K8 S73A mice
were predisposed to Fas-induced liver apoptosis (Ku et al.
1998; Ku and Omary 2006). The ablation of K18 S33 phos-
phorylation site, which regulates the binding to 14-3-3 pro-
teins, caused limited mitotic arrest and accumulation of
abnormal mitotic Wgures after partial hepatectomy (Ku
et al. 2002a).
In contrast, mice lacking K19 did not have an obvious
liver phenotype (Tao et al. 2003), but surprisingly exhibited
skeletal myopathy (Stone et al. 2007). GFAP/vimentin-
knockouts displayed compromised astrocytic function with
attenuated reactive gliosis, but no obvious alteration in the
in vitro activation of hepatic stellate cells despite the lack of
IF network (Geerts et al. 2001; Pekny and Pekna 2004).
However, in vivo studies are needed to conclusively
address the Wbrogenic potency of these transgenic mice.
Keratin variants in liver disease
The large body of evidence from animal studies showing
the importance of K8/K18 for liver homeostasis led to a
search for keratin mutations in patients with liver diseases.
Several K8/K18 variants were found to associate with the
development of cryptogenic liver disease (Ku et al. 2001).
In subsequent studies, K8/K18 were shown to represent
susceptibility genes for development of end-stage liver dis-
ease of multiple etiologies (Ku et al. 2003a, 2005). In par-
ticular, biologically signiWcant K8/K18 variants were found
in 44 of 467 liver explants (12.4%), but only in 11 out of
349 analyzed blood bank donors, which were used as a con-
trol group (P < 0.0001, prevalence OR3.8; 95% CI = 2.1–
7). Furthermore, K8/K18 variants associate with liver Wbro-
sis progression in patients with chronic hepatitis C (Strnad
et al. 2006).
K8 R340H represents the most common amino acid
altering K8/K18 variant and it is the only one, which was
signiWcantly associated with development of end-stage
liver disease (Ku et al. 2005). Larger studies are needed to
analyze the pathological signiWcance of the other less com-
mon K8/K18 variants (Ku et al. 2007).
In contrast to human association studies, experiments in
K8/K18-deWcient mice were shown to predispose mainly to
acute liver injury (Ku et al. 2007). To address this issue, we
recently analyzed a large cohort of patients with acute liver
failure (ALF). K8/K18 variants were signiWcantly more fre-
quent in total ALF patient cohort (46/345; 13.3%) and in
patients with acetaminophen-induced ALF (21/169; 12.4%)
when compared to blood bank donors (11/349; 3.7%;
P < 0.002 for both comparisons). Among the single poly-
morphisms, the K8 R340H variant was found at signiW-
cantly higher frequencies in the whole ALF cohort as well
as in the acetaminophen-induced ALF subgroup (frequency
6.6 and 7.1%, respectively vs. 3.1% in the control group;
P < 0.03 for both comparisons). In addition, transgenic
mice over-expressing K8 R340 variants displayed aug-
mented acetaminophen-induced liver toxicity. In conclu-
sion, K8/K18 are also susceptibility genes for development
of ALF and K8/K18 variants may predispose to drug-
induced liver injury (Strnad et al., unpublished data).
Up to date, only one published study analyzed the poly-
morphisms in K19 gene and found no association between
K19 variants and inXammatory bowel disease (Tao et al.
2007). Interestingly, we recently observed K19 G17S vari-
ant in three out of 190 patients with primary biliary cirrho-
sis, but none was found in control blood bank donors (200
samples; Zhong et al., unpublished data). However, larger
studies are needed to address the importance of K19 in bili-
ary diseases.
The human K8/K18 variants described above do not
cause a particular liver disease per se, they just pose a risk
factor for its development. This is diVerent from the situa-
tion in stratiWed epithelia, where keratin mutations result in
several monogenic keratin diseases (Lane and McLean
2004; Omary et al. 2004). This discrepancy may be caused
either by the intrinsic diVerence between keratins of simple
and stratiWed epithelia (Hutton et al. 1998) or by the diVer-
ent localization of the variants within the protein backbone.
To that end, disease-causing keratin mutations in stratiWed
epithelia are clustered in the highly conserved helix initia-
tion and termination motif, whereas K8/K18 disease-pre-
disposing variants are observed in more variable domains
(Owens and Lane 2004; Omary et al. 2004; Ku et al. 2007).
The disturbance in cytoprotective function of keratins is
the likely mechanisms by which K8 and K18 variants pre-
dispose to liver disorders. For example, K8/K18 are anti-
apoptotic proteins and this ability is hampered in keratin-
deWcient animals (Oshima 2002; Ku and Omary 2006; Mar-
ceau et al. 2007; Ku et al. 2007). The ways of interaction
between keratins and apoptosis are manifold. K8/K18 bind
to several apoptotic proteins and type I keratins are estab-
lished caspase substrates (Oshima 2002; Green et al. 2005;
Marceau et al. 2007). In addition, K8/K18 serve as physio-
logic kinase substrates in vitro and in transgenic mice and
an ablation of the K8 S73 phosphorylation site or introduc-
tion of the naturally occurring K8 G61C variant leads to
increased apoptosis through increased phosphorylation of
pro-apoptotic proteins (Ku et al. 2002b; Ku and Omary
2006). The keratin-mediated anti-apoptotic function may be
highly relevant given the importance of apoptosis in liver740 Histochem Cell Biol (2008) 129:735–749
123
disease and the pro-Wbrogenic properties of elevated rate of
apoptotic cell death (Friedman 2004; Malhi et al. 2006).
Keratins exhibit anti-oxidative properties, as they
sequester oxidatively damaged proteins, and similarly, the
K18 R89C variant primes the liver towards oxidative injury
(Tao et al. 2005; Zhou et al. 2005). This keratin property
might be helpful in attenuating both liver Wbrosis and acet-
aminophen-induced liver injury (Parola and Robino 2001;
Jaeschke et al. 2003). Keratins are also established stress-
inducible proteins, which are upregulated both in humans
and mice under several, mainly cholestatic conditions
(Fickert et al. 2002, 2003; Zatloukal et al. 2007; Ku et al.
2007; Strnad et al. 2008). Keratin variants may interfere
with keratin upregulation or simply result in decreased ker-
atin levels due to protein instability (as seen for K18 R89C
variant in the liver; Ku et al. 1995).
The naturally occurring K8/K18 variants interfere with
basic IF properties such as K8/K18 Wlament assembly and
keratin solubility (Ku et al. 2001; Owens et al. 2004; Ku
et al. 2007). Due to altered protein conformation, some of
them impair potentially cytoprotective keratin phosphoryla-
tion at adjacent residues (as seen in K8 G61C and K8
G434S variant; Ku et al. 2005; Ku and Omary 2006).
K8/K18 variants may also aVect organelle function, as
seen in K8 knockout mice, which exhibit altered mitochon-
drial shape, localization, and alterations in several mito-
chondrial proteins (Toivola et al. 2005).
Despite the various cytoprotective eVects of keratins,
their impact seems to be limited to certain conditions. For
example, K18 R89C mice are predisposed to Fas but not
TNF-induced apoptosis and the same mice develop more
pronounced liver Wbrosis after thioacetamide, but not after
carbon tetrachloride injection (Ku et al. 2003b; Strnad et al.
2008). It is also unknown which one of the keratin-medi-
ated eVects is important in particular disease settings. The
recently established transgenic mouse lines overexpressing
the naturally occurring K8 G61C and R340H variants will
likely oVer valuable insights in this respect (Ku and Omary
2006; Zhou et al., unpublished data).
Keratin network alteration in steatohepatitis of the 
alcoholic (ASH) and the non-alcoholic (NASH) type
Steatohepatitis is characterized by hepatocyte “ballooning”,
that is, swelling and rounding with clearing of the cyto-
plasm, which prevails in the perivenular zone and is often
associated with pericellular Wbrosis, predominantly granu-
locytic inXammation (“satellitosis”), steatosis (usually of
macrovesicular type), and cholestasis (Brunt 2004; Lefko-
witch  2005). Ballooned cells are often associated with
granular, rope- or clump-like cytoplasmic inclusions, called
Mallory-Denk bodies (MDBs) (originally also designated
alcoholic hyalin, which is, however, a misnomer since they
are not speciWc for alcoholic etiology) together with
derangement or even disappearance of the keratin IF cyto-
skeleton (Mallory 1911; Denk et al. 2000; Zatloukal et al.
2007; Fig. 1a, b). The disappearance of the keratin immu-
nostaining in ballooned hepatocytes is reasonably speciWc
for ASH and NASH, since it is not seen in ballooned cells
of viral hepatitis or toxic damage and can therefore be used
as an objective morphologic parameter in grading of steato-
hepatitis (Lackner et al. 2008). However, ballooning (with
concomitant cytoskeletal alterations) and MDB formation
are not entirely interchangeable since not all ballooned
hepatocytes contain MDBs.
MDBs are typical morphological features of ASH and
NASH, although NASH usually exhibits slightly less prom-
inent MDBs than the ones seen in ASH (Brunt 2004; Zat-
loukal et al. 2007). MDBs can also be detected after
intestinal bypass surgery for morbid obesity, in chronic
cholestasis, particularly in late stages of primary biliary cir-
rhosis, Wilson disease and other types of copper toxicosis,
various metabolic disturbances, and hepatocellular neo-
plasms (Müller et al. 2004; Zatloukal et al. 2007; Fig. 2). In
contrast, MDBs have not been observed in the context of
acute cholestasis, acute viral hepatitis and a variety of acute
toxic or drug-induced liver diseases (Jensen and Gluud
1994, Zatloukal et al. 2007; Ku et al. 2007). However, even
in potentially MDB-forming liver diseases, MDBs are
found only in a subset of patients, partially (but not com-
pletely) depending on the sensitivity of the detection
method used. For example, when using immunohistochem-
istry for keratin or ubiquitin, MDBs were found in about
70% of ASH cases in contrast to 40% seen in hematoxilin-
eosin-stained sections (Ray 1987).
This suggests that MDBs require either a speciWc patho-
genetic constellation or genetic predisposition for its forma-
tion, which is present only in a subset of patients.
Apart from MDBs, additional features may be observed
in some chronic cholestatic conditions. For example, a low
percentage of hepatocytes express keratin 7 and to a lesser
extent keratin 19 which indicate that these cells acquire fea-
tures of precursor cells which normally express keratin 8,
18, 7, and 19 during regeneration (Van Eyken et al. 1988;
Zatloukal et al. 2004). In idiopathic copper toxicosis and
hepatocellular carcinoma, MDBs may coincide with
another type of cytoplasmic inclusions, termed intracellular
hyaline bodies (IHBs), which share several components
with MDBs, but do not contain keratins (Stumptner et al.
1999; Denk et al. 2006).
The ease of MDB detection makes them attractive
morphologic markers. However, correlation between the
clinical disease manifestation/progression on one side and
hepatocyte ballooning with MDB formation on the other is
imperfect. For example, patients with severe clinicalHistochem Cell Biol (2008) 129:735–749 741
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Fig. 1 MDBs are readily detected by diVerent methods. In clinical
routine, MDBs are usually detected as eosinophilic aggregates in stan-
dard hematoxylin and eosin stained sections (a). After chromotrope
aniline blue staining, MDBs appear as blue structures, often with red
center (b). ImmunoXuorescence or immunohistochemical staining rep-
resents a more sensitive method for MDB detection than conventional
histological stainings, but is strongly dependent on the antibody used
as well as the staining protocol. MDBs can be reliably detected with
antibodies against K8/K18 [green and red channel in (c) and (d),
respectively] or p62 [red channel in (c)], whereas only some MDBs
stain with antibodies to phosphorylated keratins such as K8 pS431
antibody [green channel in (d)]. In both immunoXuorescence pictures,
MDBs are seen as yellow structure due to co-localization of both visu-
alized epitopes
Fig. 2 MDBs are seen in vari-
ous human liver diseases. Immu-
nohistochemical staining with 
p62 antibody visualizes the pres-
ence of multiple irregularly 
shaped aggregates in patients 
with alcoholic steatohepatitis 
(a), non-alcoholic steatohepati-
tis (b), Indian childhood cirrho-
sis and (c), idiopathic copper 
toxicosis (d)742 Histochem Cell Biol (2008) 129:735–749
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symptoms of ASH sometimes show only moderate histo-
pathological alterations with few or no MDBs, whereas
patients with pronounced histological alterations do not
necessarily exhibit signiWcant clinical and laboratory
abnormalities (Zatloukal et al. 2007). Despite that, con-
trolled clinical-pathologic studies comparing NASH
patients with ambulatory and hospitalized alcoholics
revealed that hepatocellular damage, presence of MDBs,
inXammation, and Wbrosis collectively correlated with
disease severity (Cortez-Pinto et al. 2003). Also in other
studies, hepatocellular ballooning and MDB formation was
positively correlated with disease progression, development
of Wbrosis, and cirrhosis and liver-related mortality (Orrego
et al.  1987; Matteoni et al. 1999; Gramlich et al. 2004;
Mendler et al. 2005).
Morphology and composition of MDBs
MDBs are irregularly shaped, usually dense cytoplasmic
inclusions of diVerent sizes (Mallory 1911). Small MDBs
arise in association with IF bundles throughout the cyto-
plasm, whereas larger MDBs are often seen in the perinu-
clear region (Denk et al. 2000; Zatloukal et al. 2007; Ku
et al. 2007). Ultrastructurally, they usually consist of hap-
hazardly arranged Wlamentous rods, approximately 10–
15 nm in diameter, covered by a fuzzy coat (designated as
type II by Yokoo et al. 1972). In addition, MDBs with an
electron dense granular to amorphous center (designated
type 3) are seen predominantly in older inclusions, and Wla-
ments in parallel arrangement were also described (desig-
nated as type I) but seem to be exceedingly rare (Yokoo
et al. 1972). Keratins 8 and 18, sequestosome 1/p62 (p62)
and ubiquitin are major, and low and high molecular weight
heat shock proteins (HSP 70, HSP 25), but also proteins of
the protein degradation machinery, are minor constituents
(Denk et al. 2000; Riley et al. 2002, 2003; Zatloukal et al.
2007; Ku et al. 2007; Figs. 1c, d; Fig. 2). Keratins 7, 19,
and 20 have also occasionally been detected (Cadrin et al.
1990; Dinges et al. 1992). The K8/K18 within MDBs
exhibit increased -sheet structure (Cadrin et al. 1991;
Kachi et al. 1993), are hyperphosphorylated, partially
degraded and cross-linked (Hazan et al. 1986; Zatloukal
et al.  1992; Cadrin et al. 1995; Stumptner et al. 2000;
Fig. 1d). The list of MDB components is likely to grow
since, in addition to intrinsic components, proteins non-spe-
ciWcally incorporated in the aggregate have to be expected.
Pathogenesis of MDBs
Studies on MDB formation and composition are greatly
enhanced by the availability of animal models. MDBs can
be induced under standardized conditions and their fate fol-
lowed in mouse liver by chronic griseofulvin or 3,5-dieth-
oxycarbonyl-1,4-dihydrocollidine (DDC) administration
(Denk et al. 1975; Yokoo et al. 1982; Denk et al. 2000; Zat-
loukal et al. 2004, 2007; Fig. 3c, d).
In patients, MDB formation is usually a chronic process
requiring several years of alcohol intoxication or metabolic
imbalance, that is, in association with the metabolic syn-
drome, Wilson disease, other metabolic disorders, and
chronic cholestasis. An exception is idiopathic copper toxi-
cosis of children in which end stage liver disease associated
with MDB formation occurs at very early age (Müller et al.
2004; Zatloukal et al. 2007). Surprisingly, in alcoholics
recovered from ASH, an alcohol excess may almost instan-
taneously lead to MDB recurrence, a situation which has
been compared to an immunologic response and termed
“toxic memory” (Jensen and Gluud 1994; Denk et al.
2000). The animal model of MDB formation does not only
reproduce the structural and morphological features seen in
humans, but also the phenomenon of “toxic memory”
(Fig. 3; Denk et al. 2000; Zatloukal et al. 2004, 2007). To
induce MDBs in mice, griseofulvin or DDC is usually fed
for 2–3 months. MDB formation in mice is reversible, since
MDBs disappear after recovery on standard diet for
1 month. However, after rechallenge of the recovered
(“primed”) animals, MDBs reappear within a few days
(Denk et al. 2000; Zatloukal et al. 2004,  2007). Rapid
MDBs formation in primed mice is rather non-speciWc,
since it can be triggered by a variety of stress conditions
including colchicine (but not by lumicolchicine), bile acids,
bile duct ligation, several other toxins, and proteasome
inhibitors which were unable to induce MDBs in the naïve
animal (Zatloukal et al. 2007, and references therein). The
reasons for this phenomenon are as yet unclear but point to
a Wnal common pathway activated by the trigger.
The availability of cellular and animal models of MDB
formation led to valuable insights into the mechanism of
MDB formation. Several pathogenic mechanisms were
implicated in this process (Fig. 4; Dobson 2004):
1. Enhanced oxidative stress
2. Disproportional K8/K18 expression together with
keratin modiWcations
3. Chaperone dysfunction
4. Elevated p62 levels
5. InsuYcient protein degradation
Ad 1. The MDB-inducing conditions both in humans and
mice cause elevated levels of oxidative stress (Tephly et al.
1981; Mehta et al. 2002; Dey and Cederbaum 2006; Farrell
and Larter 2006) and MDBs themselves were shown to con-
tain misfolded keratins with increased -sheet formation
(Cadrin et al. 1991; Kachi et al. 1993). Recent animal studies
highlight the importance of altered methyl group metabolism
and mitochondrial stress in this process (Li et al. 2008;Histochem Cell Biol (2008) 129:735–749 743
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Zatloukal et al., unpublished data). During DDC detoxiWca-
tion, N-methylprotoporphyrin is formed through transfer of
a methyl group to heme moieties (Tephly et al. 1981).
N-methylprotoporphyrin subsequently acts as a potent inhib-
itor of ferrochelatase, thereby causing porphyria (Tephly
et al. 1980). Accordingly, MDB formation and DDC eVects
can be eVectively attenuated by feeding S-adenosylmethio-
nine, that is a compound involved in methyl group transfer
(Li et al. 2008). This is reminiscent of the situation in ASH,
which is also associated with disrupted methyl group metab-
olism (Schalinske and Nieman 2005).
DDC targets mitochondria, where it reacts with cyto-
chrome P450 (Marks et al. 1985). An unbiased microarray
analysis identiWed cytochrome P450 (Cyp) 2a5 as a major
gene induced both after DDC exposure and particularly
after DDC re-challenge. Moreover, Cyp2e5 overexpression
spacially coincides with MDB formation (Zatloukal et al.,
unpublished data). Cyp2a5 is a “leaky” cytochrome which
produces reactive oxygen species (Lewis et al. 1989). In
that sense, it resembles human Cyp2E1, which was impli-
cated as a source of oxidative stress in the pathogenesis of
ASH and NASH (Villeneuve and Pichette 2004).
To address the role of mitochondrial stress in MDB for-
mation, we re-fed DDC-primed mice with DDC alone or in
combination with the mitochondria-targeted antioxidant
mito Q (Smith et al. 2003). Mito Q co-administration atten-
uated both MDB formation and DDC-induced liver dam-
age. Therefore, mitochondrial oxidative stress seems to be
involved in MDB formation in mice which is in good con-
cordance to the mitochondrial dysfunction seen both in
ASH and NASH patients (Pessayre 2007; Mantena et al.
2008; Zatloukal et al., unpublished data).
Ad 2. Keratins are major constituents of MDBs and both
altered K8/K18 expression and keratin modiWcation seems
to aVect MDB formation (Zatloukal et al. 2007; Ku et al.
2007). Griseofulvin/DDC feeding leads to rapid induction of
K8/K18 expression with disproportional K8 > K18 levels
(Denk et al. 2000). The elevated K8/K18 ratio is crucial for
MDB formation as shown in K18-knockout and K8 over-
expressing animals, who are predisposed to MDB formation
already upon short exposure to DDC and even form MDBs
spontaneously during aging (Magin et al. 1998; Nakamichi
et al. 2005). Accordingly, K8-null or K18 overexpressing
mice are resistant to MDB formation and the protective
function of K18 is not aVected by its phosphorylation status
or mutation (Zatloukal et al. 2000; Harada et al. 2007).
However, the exclusive MDB inducing property of K8 in
vivo cannot be reproduced in vitro, where aggregates resem-
Fig. 3 MDBs formed in DDC-
fed animals resemble inclusion 
bodies observed in human dis-
eases. Liver sections were dou-
ble labeled with antibodies to 
K8/K18 (green) and p62 (red). 
Samples from mouse fed DDC 
for 12 weeks (d) and from a pa-
tient with alcoholic steatohepati-
tis (b) exhibit multiple 
irregularly shaped inclusion 
bodies, which appear yellow due 
to presence of both epitopes. In 
contrast, control human (a) and 
mouse liver (c) display an un-
aVected keratin network with no 
apparent p62 staining. Note that 
DDC feeding leads to deposition 
of protoporphyrin, which can be 
seen as occasional blue pigment 
in (d)744 Histochem Cell Biol (2008) 129:735–749
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bling MDBs can also be produced by transfection of K18
(Nakamichi et al. 2002; Stumptner et al. 2007).
Among posttranslational modiWcations, MDB formation
is associated with K8 hyperphosphorylation and transami-
dation (Zatloukal et al. 1992; Stumptner et al. 2000). In a
recent study, ablation of K8 S73 phosphorylation site in
transgenic mice resulted in diminished MDB formation
after DDC exposure (Harada et al., unpublished results).
Several potential mechanisms might be responsible for this
observation. K8 S73 is a well-known p38 kinase target site
and p38 up-regulation induces keratin network reorganiza-
tion with subsequent granule formation (Ku et al. 2002b;
Wöll et al. 2007). P38 kinase-induced keratin network
reorganization might be a necessary prerequisite for MDB
formation, since p38 kinase inhibition prevented MDB
formation in vitro (Nan et al. 2006). Alternatively, K8
hyperphosphorylation may induce MDB formation through
inhibition of K8 degradation, which results in increased
K8/K18 ratio (Ku and Omary 2000).
MDBs contain highly cross-linked keratins and the abla-
tion of tissue transglutaminase eVectively inhibits DDC-
induced MDB formation (Zatloukal et al. 1992; Strnad
et al. 2007). Since K8 is a much better in vitro transgluta-
minase substrate than K18 and highly cross-linked proteins
found in MDB-forming mice contain K8, but not K18, it
was suggested that excessive K8 gets preferentially tran-
samidated and acts as a nucleus for MDB formation. This is
supported by studies in transgenic mice, where K8 overex-
pression accelerates and K18 excess inhibits not only
MDB, but also cross-link formation (Strnad et al. 2007).
Ad 3. MDBs were shown to contain misfolded keratins
(Cadrin et al. 1991, Kachi et al. 1993). The protein misfold-
ing is usually counteracted by the reparative function of
chaperones (Ross and Poirier 2004; Macario and Conway
de Macario 2005; Bukau et al. 2006), however, DDC feed-
ing is associated with diminished chaperone expression,
persistent chaperone modiWcations and impairment of
chaperone function (Strnad et al. submitted). Similarly,
chaperone function is impaired in a rat model of chronic
alcoholic liver disease (Carbone et al. 2005).
Ad 4. P62 is a stress-inducible protein with multiple
functions which is a constituent of multiple inclusion bod-
ies termed sequestosomes (Shin 1998; Kuusisto et al. 2001;
Zatloukal et al. 2002; Moscat et al. 2007). It binds proteins
polyubiquitinated at lysine 63 and shuttles them for prote-
asomal or autophagic degradation (Vadlamudi et al. 1996;
Bjorkoy et al. 2005; Seibenhener et al. 2004; Wooten et al.
2008). p62 has been shown to enhance aggregate formation
(Donaldson et al. 2003; Wang et al. 2005; Komatsu et al.
2007; Gal et al. 2007; Nezis et al. 2008). p62 action is ben-
eWcial under normal conditions, since it prevents accumula-
tion of abnormal proteins (Bjorkoy et al. 2005; Ramesh
Babu et al. 2008), but may become harmful when protein
degradation is inhibited (Komatsu et al. 2007).
There are several lines of evidence implicating p62 (con-
taining the ubiquitin binding site) in MDB formation. In
cell culture experiments, protein aggregates resembling
MDBs formed only after p62 co-transfection, but not when
K8, K18, and ubiquitin were transfected alone or in combi-
nation (Stumptner et al. 2007). Furthermore, p62 was
rapidly induced in DDC-fed mice with p62-containing
aggregates preceding the formation of MDBs (Stumptner
et al.  2002). Furthermore, p62 inhibition attenuated,
whereas p62 overexpression enhanced MDB formation in
DDC-primed hepatocytes (Nan et al. 2006).
Ad 5. Accumulation of protein aggregates, as seen dur-
ing MDB formation, is counteracted by proteasomal or
autophagic degradation (Glickman and Ciechanover 2002;
Williams et al. 2006) and both degradation machineries are
Fig. 4 MDBs formation results from a complex interplay of several
contributing factors. Since the cytoplasm represents a hydrophilic mi-
lieu, all exposed hydrophobic molecules (depicted by red stretches
within the protein) are predisposed to aggregation. Properly folded
proteins usually hide their hydrophobic stretches inside, but these get
exposed in nascent protein chains or after proteins become misfolded
as a consequence of oxidative stress. Chaperones bind to these hydro-
phobic residues and facilitate protein refolding. Alternatively, dam-
aged proteins become polyubiquitinated and degraded either by the
proteasomal or autophagic system. MDB-causing agents typically gen-
erate extensive amount of oxidative stress with increased protein mis-
folding. In addition, chaperone levels are downregulated and/or
chaperone function is compromised. Dysbalanced K8/K18 expression
precedes MDB formation, likely increases keratin misfolding and pre-
disposes to posttranslational modiWcations, which may interfere with
keratin refolding and/or repair. Accumulated misfolded proteins are
sequestered as inclusions through the action of p62. p62 also shuttles
polyubiquitinated proteins to degradative machineries. However, pro-
teasomal degradation might be impaired by oxidative stress, may not
be able to digest highly cross-linked protein species or might simply be
overwhelmed by the excessive supply. On the other hand, autophagy is
upregulated during MDB formation in mice and additional stimulation
of autophagy attenuates MDB formation in certain conditions. Of note,
supplementation of S-adenosylmethionine or mitochondrially targeted
antioxidants eVectively diminishes MDB formation, thereby pointing
to a central role of oxidative stress in MDB generationHistochem Cell Biol (2008) 129:735–749 745
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active in the liver. For example, conditional knock-out of
the autophagy-related gene 7 (Atg7) leads to development
of ubiquitin-positive inclusions in hepatocytes (Komatsu
et al. 2005). Similarly, proteasomes seem to interact with
MDBs and inhibition of proteasomal degradation leads to
formation of MDB-like structures both in vitro and in
DDC-primed mice (Harada et al. 2003; Bardag-Gorce et al.
2002; Riley et al. 2002; French et al. 2001). Furthermore,
autophagic degradation is upregulated in DDC-fed mice
and its further stimulation with rapamycin attenuates spon-
taneous MDB formation in K8 overexpressing mice
(Harada et al. 2008).
In contrast, MDB formation might be facilitated by pro-
teasomal impairment, since MDBs are preferentially seen
in proteasome-depleted hepatocytes (Bardag-Gorce et al.
2001). In addition, an aberrant form of ubiquitin, termed
[UBB + 1] arising as a consequence of molecular misread-
ing, is observed in MDBs and may inhibit proteasomal
function (McPhaul et al. 2002; Lindsten et al. 2002). Simi-
larly, alcohol and aging, both potential inducers of MDBs
can be associated with decreased proteasome function
(Hayashi and Goto 1998; Fataccioli et al. 1999).
However, aggregate formation must not always be
caused by a general inhibition in protein degradation. The
degradative capacity may simply be overwhelmed by
increased amounts of misfolded proteins. Alternatively,
certain proteins may not be easily degradable, such as pro-
teins with long polyglutamine stretches (Venkatraman et al.
2004). The latter scenario may apply to DDC-fed mice,
which exhibit an accumulation of ubiquitinated protein
only in the highly insoluble protein fraction (Strnad et al.
2007). This fraction is characterized by highly cross-linked
protein species generated through extensive transamidation,
which may make them resistant to proteolytic degradation
(Strnad et al. 2007).
Pathologic signiWcance of MDBs
In principle, cytoplasmic protein aggregates can be beneW-
cial, detrimental or inert depending on the context. In many
pathologic situations aggregation seems to be a protective
response if the Wrst lines of defense, that is, refolding and
degradation, fail by sequestration of potentially harmful
proteins (Arrasate et al. 2004; Bodner et al. 2006). On the
other hand, large protein aggregates can be detrimental
either by mechanical interference with cellular transport
processes (e.g., shown with microtubule-dependent trans-
port in neurons), deprivation of the cell of vital components
by aggregation or coaggregation and by overwhelming/
inhibiting the capacity of the chaperone system and/or the
protein degradation machinery by indigestible material
(Alonso et al. 1997; Stenoien et al. 1999; Suhr et al. 2001;
Bence et al. 2001; Lee et al. 2004; Grune et al. 2004). It can
be expected, therefore, that in diVerent cell systems and
pathologic conditions inclusion bodies diVer regarding their
cellular eVects and consequences. MDBs per se do not
seem to compromise the viability of transfected tissue cul-
ture cells (Stumptner et al. 2007) or hepatocytes in vivo,
who even exhibit an activated phenotype (Denk et al.
2000). Further studies are needed to deWnitely characterize
the molecular consequences of MDB formation.
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